SPL Sitara Peroxide Limited

Sitara Peroxide Limited (SPL) financial ratios

The current ratio stood at 1.72× and debt was — of equity.

FY2026 vs the Chemical median

Return on assets (ROA): 0.5%; Sector median 7.1%
Current ratio: 1.72×; Sector median 1.46×

Median of the 25 companies in the sector with the figure for their latest fiscal year.

SPL financial ratios (annual) (Rs mn)
Rs mn	FY2026 Jul 2025 – Jun 2026	FY2025 Jul 2024 – Jun 2025	FY2024 * Jul 2023 – Jun 2024	FY2023 Jul 2022 – Jun 2023	FY2022 Jul 2021 – Jun 2022	FY2021 Jul 2020 – Jun 2021	FY2020 Jul 2019 – Jun 2020	FY2019 Jul 2018 – Jun 2019	FY2018 Jul 2017 – Jun 2018	FY2017 Jul 2016 – Jun 2017	FY2016 Jul 2015 – Jun 2016	FY2015 Jul 2014 – Jun 2015	FY2014 Jul 2013 – Jun 2014	FY2013 Jul 2012 – Jun 2013	FY2012 Jul 2011 – Jun 2012	FY2011 Jul 2010 – Jun 2011	FY2010 Jul 2009 – Jun 2010	FY2009 Jul 2008 – Jun 2009	FY2008 Jul 2007 – Jun 2008	FY2007 Jul 2006 – Jun 2007
Profitability
Gross margin	—	—	(1,345.3%)	(33.2%)	(3.6%)	10.3%	18.5%	26.0%	11.5%	4.3%	14.5%	8.5%	20.1%	24.7%	15.5%	39.0%	4.5%	16.3%	6.7%	—
EBITDA margin	—	—	(119.2%)	(41.7%)	(4.2%)	12.9%	20.3%	27.2%	16.6%	11.9%	22.8%	18.9%	25.6%	31.6%	25.2%	46.3%	14.7%	22.6%	22.9%	—
Operating margin	—	—	(1,352.8%)	(64.5%)	(17.4%)	3.1%	9.8%	18.1%	2.9%	(5.1%)	8.9%	5.2%	13.7%	16.2%	8.1%	33.5%	(7.5%)	5.9%	5.6%	—
Pre-tax margin	—	—	(2,051.6%)	(91.4%)	(22.2%)	0.7%	5.1%	13.7%	(2.5%)	(12.1%)	2.1%	(5.3%)	2.3%	(0.9%)	(17.5%)	13.9%	(37.5%)	(29.9%)	(30.7%)	—
Net margin	—	—	(1,136.5%)	(96.2%)	(19.6%)	1.9%	4.3%	10.2%	(4.9%)	(8.2%)	1.3%	(3.9%)	0.4%	(1.7%)	(20.2%)	12.9%	(24.6%)	(15.9%)	(20.6%)	—
Effective tax rate	(946.4%)	—	—	—	—	(154.2%)	16.5%	25.8%	—	—	38.1%	—	84.9%	—	—	7.3%	—	—	—	—
Returns
Return on equity (ROE)	—	(20.2%)	(13.4%)	(45.9%)	(14.8%)	1.5%	3.7%	11.2%	(4.5%)	(7.3%)	1.4%	(4.1%)	0.5%	(2.7%)	(24.6%)	20.2%	(21.6%)	(14.4%)	(12.0%)	—
Return on assets (ROA)	0.5%	(7.6%)	(5.2%)	(21.6%)	(8.5%)	0.9%	2.0%	5.5%	(1.9%)	(2.8%)	0.5%	(1.5%)	0.2%	(0.7%)	(7.1%)	5.9%	(6.3%)	(4.0%)	(2.8%)	—
Return on invested capital (ROIC)	—	—	—	—	—	4.7%	5.4%	10.4%	—	—	3.0%	—	1.2%	—	—	15.3%	—	—	—	—
Liquidity
Current ratio	1.72×	0.28×	0.35×	0.44×	0.91×	1.91×	1.70×	1.28×	1.02×	0.84×	1.03×	1.04×	1.19×	0.93×	0.62×	0.79×	0.74×	0.79×	0.72×	0.98×
Quick ratio	1.52×	0.06×	0.13×	0.21×	0.59×	0.92×	0.70×	0.63×	0.44×	0.36×	0.50×	0.42×	0.34×	0.30×	0.17×	0.24×	0.25×	0.23×	0.18×	0.58×
Leverage
Debt to equity	—	49.5%	42.5%	49.5%	19.1%	18.0%	25.2%	33.4%	47.9%	79.9%	79.1%	103.9%	107.8%	238.0%	250.0%	199.4%	242.4%	190.9%	291.8%	262.6%
Debt to capital	—	33.1%	29.8%	33.1%	16.0%	15.3%	20.2%	25.0%	32.4%	44.4%	44.2%	50.9%	51.9%	70.4%	71.4%	66.6%	70.8%	65.6%	74.5%	72.4%
Debt to assets	17.4%	17.6%	16.8%	19.0%	10.5%	10.9%	14.2%	17.1%	22.4%	31.1%	31.2%	38.3%	41.1%	63.1%	64.7%	62.6%	65.3%	59.2%	66.6%	61.0%
Assets to equity	—	2.66×	2.57×	2.12×	1.74×	1.71×	1.86×	2.04×	2.31×	2.55×	2.62×	2.66×	3.02×	3.82×	3.48×	3.42×	3.44×	3.62×	4.34×	—
Efficiency
Asset turnover	—	0.00×	0.00×	0.22×	0.44×	0.48×	0.47×	0.54×	0.39×	0.35×	0.40×	0.40×	0.48×	0.42×	0.35×	0.46×	0.25×	0.25×	0.13×	—
Receivable days days	—	—	6,091	194	101	81	99	83	105	131	105	79	54	57	53	40	70	71	102	—
Inventory days days	—	—	579	122	106	151	173	145	176	193	182	183	180	218	205	179	192	257	493	—
Payable days days	—	—	899	141	62	52	82	93	117	137	114	76	51	59	43	29	51	89	118	—
Cash conversion cycle days	—	—	5,768	175	145	180	190	134	164	187	173	186	183	215	215	190	210	239	477	—
Dividends
Dividend payout ratio	—	—	—	—	—	0.0%	0.0%	0.0%	—	—	0.0%	—	0.0%	—	—	0.0%	—	—	—	—
Earnings retention rate	—	—	—	—	—	1.00×	1.00×	1.00×	—	—	1.00×	—	1.00×	—	—	1.00×	—	—	—	—

Ratios as reported for each fiscal year; returns are on average equity / assets. Debt ratios are percentages; turnover in times; working-capital measures in days.

SPL: frequently asked questions

What is SPL's EPS?

Sitara Peroxide Limited reported basic earnings per share of Rs 2.68 for FY2026 (Jul 2025 – Jun 2026).

What is SPL's P/E ratio?

At the closing price of Rs 48.49 on 16 Oct 2026, SPL trades at a P/E of 18.1× based on EPS of Rs 2.68 (FY2026).

Information only, not investment advice.